Interventions for itch in people with advanced chronic kidney disease
Referencias
Additional references
Andersen L, Friedberg M, Lokkegaard N. Naloxone in the treatment of uremic pruritus: a case history. Clinical Nephrology1984; Vol. 21, issue 6:355‐6. [MEDLINE: 6467691]
Burks TF, Buck SH, Miller MS. Mechanisms of depletion of substance P by capsaicin. Federation Proceedings 1985;44(9):2531‐4. [MEDLINE: 2581820]
Carmichael AJ, Dickinson F, McHugh MI, Martin AM, Farrow M. Magnesium free dialysis for uraemic pruritus. BMJ 1988;297(6663):1584‐5. [MEDLINE: 3147085]
Che‐Yi C, Wen CY, Min‐Tsung K, Chiu‐Ching H. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrology Dialysis Transplantation 2005;20(9):1912‐5. [MEDLINE: 15985509]
Chen ZJ, Cao G, Tang WX, Lv XY, Huang SM, Qin W, et al. A randomized controlled trial of high‐permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clinical & Experimental Dermatology 2009;34(6):679‐83. [MEDLINE: 19175617]
De Marchi S, Cecchin E. Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin. Clinical Science 1991;81(1):113‐21. [MEDLINE: 1649718]
Dimković N, Djukanović L, Radmilović A, Bojić P, Juloski T. Uremic pruritus and skin mast cells. Nephron 1992;61(1):5‐9. [MEDLINE: 1528340]
Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, et al. UVB exposure‐induced systemic modulation of Th1‐ and Th2‐mediated immune responses. Immunology 1999;97(3):506‐14. [MEDLINE: 10447774]
Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Relief of uremic pruritus with ultraviolet phototherapy. New England Journal of Medicine 1977;297(3):136‐8. [MEDLINE: 865585]
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [MEDLINE: 21195583]
Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of "uremic" itching after subtotal parathyroidectomy. New England Journal of Medicine 1968;279(13):695‐7. [MEDLINE: 5670910]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [MEDLINE: 12958120]
Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kaku H, Fujita Y, Yago H, Naka F, Kawakubo H, Nakano K, et al. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: plasma levels of substance P, somatostatin, IgE, PTH and histamine. Nihon Jinzo Gakkai Shi [Japanese Journal of Nephrology] 1990;32(3):319‐26. [MEDLINE: 1693990]
Kato A, Takita T, Furuhashi M, Takahashi T, Watanabe T, Maruyama Y, et al. Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necrosis factor‐alpha. Artificial Organs 2001;25(6):441‐7. [MEDLINE: 11453873]
Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, Tsai PJ, et al. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. British Journal of Dermatology 2011;165(3):633‐9. [MEDLINE: 21668425]
Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H. Effect of a novel kappa‐receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double‐blind, placebo‐controlled study. Nephrology Dialysis Transplantation 2010;25(4):1251‐7. [MEDLINE: 19926718]
Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, et al. Unidirectional cross‐activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 2011;147(2):447‐58. [MEDLINE: 22000021]
Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. New England Journal of Medicine 1968;279(13):697‐700. [MEDLINE: 5670911]
Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clinical Nephrology 1985;23(6):285‐8. [MEDLINE: 4028525]
Mettang T, Pauli‐Magnus C, Alscher DM. Uraemic pruritus ‐ new perspectives and insights from recent trials. Nephrology Dialysis Transplantation 2002;17(9):1558‐63. [MEDLINE: 121918205]
Mistik S, Utas S, Ferahbas A, Tokgoz B, Unsal G, Sahan H, et al. An epidemiology study of patients with uremic pruritus. Journal of the European Academy of Dermatology & Venereology 2006;20(6):672‐8. [MEDLINE: 16836494]
Naini AE, Harandi AA, Khanbabapour S, Shahidi S, Seirafiyan S, Mohseni M. Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi Journal of Kidney Diseases & Transplantation 2007;18(3):378‐81. [PUBMED: 17679749]
Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney International 2006;69(9):1626‐32. [MEDLINE: 16672924]
Pan ZZ. mu‐Opposing actions of the kappa‐opioid receptor. Trends in Pharmacological Sciences1998; Vol. 19, issue 3:94‐8. [MEDLINE: 9584625]
Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. American Journal of Kidney Diseases 2007;50(1):11‐20. [MEDLINE: 17591521]
Pauli‐Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double‐blind, placebo‐controlled crossover study. Journal of the American Society of Nephrology 2000;11(3):514‐9. [MEDLINE: 10703675]
Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996;348(9041):1552‐4. [MEDLINE: 8950882]
Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation 2006;21(12):3495‐505. [MEDLINE: 16968725]
Rayner HC. Itching in renal failure: a curse with a cure. Journal of Renal Nursing 2013;5(4):75‐9. [DOI: 10.12968/jorn.2013.5.4.178]
Robinson‐Bostom L, DiGiovanna JJ. Cutaneous manifestations of end‐stage renal disease. Journal of the American Academy of Dermatology 2000;43(6):975‐86. [MEDLINE: 11100013]
Stockenhuber F, Sunder‐Plassmann G, Balcke P. Increased plasma histamine levels in chronic renal failure. New England Journal of Medicine 1987;317(6):386. [MEDLINE: 3600734]
Tan JK, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. Journal of the American Academy of Dermatology 1991;25(5 Pt 1):811‐8. [MEDLINE: 1839393]
Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, et al. Kappa‐opioid system in uremic pruritus: multicenter, randomized, double‐blind, placebo‐controlled clinical studies. Journal of the American Society of Nephrology 2005;16(12):3742‐7. [MEDLINE: 16251241]
Xander C, Meerpohl JJ, Galandi D, Buroh S, Schwarzer G, Antes G, et al. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD008320.pub2]
Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end‐stage renal disease. Journal of the American Academy of Dermatology 2003;49(5):842‐6. [MEDLINE: 14576662]
